ADS Biotec, along with its parent company ADSTEC (Japan), is a global leader in the development, manufacture and sale of automated instruments and consumables for use in cytogenetic, pathology and research laboratories.

Cancer Genomics: From Tiny Samples to Big Findings

  • 09/03/2022
  • 793 Views

GEN Genetic Engineering and Biotechnology News with John McCloskey.

Original article by Kathy Liszews – GEN

Cytogenetics automation

Diseases such as cancer often feature chromosomal breaks, rearrangements, and added or missing segments. Cytogenetic (that is, chromosomal) analyses can help clinicians improve their diagnostic capabilities, treatment decisions, and outcome assessments.

“Certain processes in the cytogenetics workflow, which for many years have been performed manually, are slow and labor intensive,” said John McCloskey, director of sales, North America, ADS Biotec. “There is an ongoing shift by many laboratories to adopt automation for workflow tasks that occur upstream of analysis and pathology review.

Click here to read more

For More Information:

ADS Biotec Inc.
Stavros Papadimitriou – Vice President of Marketing
info@adsbiotec.com
www.adsbiotec.com